DE69934305D1 - Verwendung von dexmedetomidine zur sedierung auf der intensivstation - Google Patents

Verwendung von dexmedetomidine zur sedierung auf der intensivstation

Info

Publication number
DE69934305D1
DE69934305D1 DE69934305T DE69934305T DE69934305D1 DE 69934305 D1 DE69934305 D1 DE 69934305D1 DE 69934305 T DE69934305 T DE 69934305T DE 69934305 T DE69934305 T DE 69934305T DE 69934305 D1 DE69934305 D1 DE 69934305D1
Authority
DE
Germany
Prior art keywords
dexmedetomidine
sedation
intensive station
intensive
station
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934305T
Other languages
English (en)
Other versions
DE69934305T2 (de
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69934305(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Oyj, Hospira Inc filed Critical Orion Oyj
Application granted granted Critical
Publication of DE69934305D1 publication Critical patent/DE69934305D1/de
Publication of DE69934305T2 publication Critical patent/DE69934305T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69934305T 1998-04-01 1999-03-31 Verwendung von dexmedetomidine zur sedierung auf der intensivstation Expired - Lifetime DE69934305T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US80287P 1998-04-01
US11094498P 1998-12-04 1998-12-04
US110944P 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (2)

Publication Number Publication Date
DE69934305D1 true DE69934305D1 (de) 2007-01-18
DE69934305T2 DE69934305T2 (de) 2007-07-12

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934305T Expired - Lifetime DE69934305T2 (de) 1998-04-01 1999-03-31 Verwendung von dexmedetomidine zur sedierung auf der intensivstation

Country Status (27)

Country Link
EP (1) EP1069893B1 (de)
JP (1) JP4606581B2 (de)
KR (1) KR20010034728A (de)
CN (1) CN1168441C (de)
AR (1) AR015744A1 (de)
AT (1) ATE347359T1 (de)
AU (1) AU754484B2 (de)
BG (1) BG64540B1 (de)
BR (1) BR9909872A (de)
CA (1) CA2326339C (de)
CZ (1) CZ301013B6 (de)
DE (1) DE69934305T2 (de)
DK (1) DK1069893T3 (de)
EA (1) EA005524B1 (de)
ES (1) ES2278441T3 (de)
GB (1) GB2352972B (de)
HU (1) HU229162B1 (de)
IL (1) IL138416A (de)
NO (1) NO329194B1 (de)
NZ (1) NZ507203A (de)
PL (1) PL192517B1 (de)
PT (1) PT1069893E (de)
SI (1) SI1069893T1 (de)
SK (1) SK286160B6 (de)
TR (1) TR200002837T2 (de)
TW (1) TW552136B (de)
WO (1) WO1999049854A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030347A1 (en) 1999-10-29 2001-05-03 Orion Corporation Treatment or prevention of hypotension and shock
IL164217A0 (en) * 2002-04-08 2005-12-18 Guilford Pharm Inc Pharmaceutical compositions containing water-soluble propofol and methods of administering same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
EP2081562B1 (de) 2006-09-20 2016-02-24 The Board of Regents of The University of Texas System Verfahren zur abgabe von flüchtigen anästhetika für die regionalanästhesie und/oder schmerzlinderung
JP5789100B2 (ja) 2008-01-22 2015-10-07 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 抽出溶媒を含む、局部的な麻酔および／または疼痛低減のための揮発性麻酔薬組成物
US20110021588A1 (en) * 2009-05-15 2011-01-27 Recro Pharma, Inc. Sublingual dexmeditomidine compositions and methods of use thereof
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
PE20142314A1 (es) 2011-12-11 2015-01-23 Recro Pharma Inc Composiciones intranasales de dexmedetomidina y metodos de uso de ellas
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
LT2906213T (lt) * 2012-10-15 2018-02-26 Orion Corporation Baimės triukšmui palengvinimo veterinarinis būdas
CN105473669A (zh) 2013-07-24 2016-04-06 I-技术有限公司 作为抑制剂的对映异构体左旋美托咪啶在海洋生物污损表面附着的应用
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
TWI704933B (zh) * 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
KR101831290B1 (ko) * 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
WO1999049854A2 (en) 1999-10-07
CA2326339A1 (en) 1999-10-07
CA2326339C (en) 2008-12-23
ES2278441T3 (es) 2007-08-01
EA200001010A1 (ru) 2001-02-26
CZ20003484A3 (cs) 2002-01-16
HU229162B1 (hu) 2013-09-30
IL138416A (en) 2005-07-25
SK286160B6 (sk) 2008-04-07
KR20010034728A (ko) 2001-04-25
EA005524B1 (ru) 2005-04-28
ATE347359T1 (de) 2006-12-15
TW552136B (en) 2003-09-11
WO1999049854A3 (en) 1999-11-18
NO20004931D0 (no) 2000-09-29
CN1168441C (zh) 2004-09-29
CZ301013B6 (cs) 2009-10-14
GB2352972A (en) 2001-02-14
BG64540B1 (bg) 2005-07-29
DE69934305T2 (de) 2007-07-12
IL138416A0 (en) 2001-10-31
DK1069893T3 (da) 2007-03-19
NZ507203A (en) 2003-03-28
AR015744A1 (es) 2001-05-16
SK14362000A3 (sk) 2002-03-05
JP4606581B2 (ja) 2011-01-05
CN1295473A (zh) 2001-05-16
PT1069893E (pt) 2007-01-31
NO20004931L (no) 2000-09-29
EP1069893B1 (de) 2006-12-06
BR9909872A (pt) 2007-11-20
PL343553A1 (en) 2001-08-27
HUP0101498A1 (hu) 2002-03-28
NO329194B1 (no) 2010-09-13
AU3149499A (en) 1999-10-18
SI1069893T1 (sl) 2007-04-30
TR200002837T2 (tr) 2001-01-22
HUP0101498A3 (en) 2002-06-28
JP2002509880A (ja) 2002-04-02
EP1069893A2 (de) 2001-01-24
BG104797A (en) 2001-07-31
PL192517B1 (pl) 2006-10-31
GB0024932D0 (en) 2000-11-29
GB2352972B (en) 2003-05-21
AU754484B2 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
DE69934305D1 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
DE69932397D1 (de) Zusammensetzung zur äusserlichen verwendung
DE69833134D1 (de) Verwendung aliphatischer amine zur verminderung von oxalat
DE69933896D1 (de) Verfahren zur Aufrechterhaltung der Gleichförmigkeit von Farbmessgeräten
DE69903655D1 (de) Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr
DE69818327D1 (de) Direktmischempfänger zur Unterdrückung von Offset-Gleichspannungen
FI982388A (fi) Menetelmä staattisen sähkön eliminoimiseksi
ATE267184T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung zur hemmung der hormonsensitiven lipase
DE69917447D1 (de) System zur unterstüztung der bereitstellung von diensten
DE60300191T8 (de) Kommunikationsterminal zur Beschränken der Verwendung von Inhalten
DE69715870D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
ID29128A (id) Gen untuk biosintesis epotilon
DE19980175D2 (de) Farbdose
FI990509A0 (fi) Häiriönpoistomenetelmä
DE59702070D1 (de) Anordnung zur weitförderung von dickstoffen
DE69937136D1 (de) Lackiervorrichtung
ATA179498A (de) Theodolit
DE19983191T1 (de) Verfahren zur Steigerung der Effizienz von Geschäften
DE50011084D1 (de) Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
DE59913832D1 (de) Gelenkanordnung zur übertragung von drehmomentgeeigneten gelenkwellen
FI982378A0 (fi) Järjestely kohteen tutkimiseen
DE69914363D1 (de) Verfahren zur regulierung der molekulargewichtsverteilung von polyetherglykol
DE69905627D1 (de) Anzeige der Verteilung von Hilfsdaten
DE69939893D1 (de) Router zur wegeleitung von datenpaketen
FI980371A0 (fi) Transportanordning innefattande en behaollarkonstruktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1069893

Country of ref document: EP

Representative=s name: WINTER, BRANDL, FUERNISS, HUEBNER, ROESS, KAIS, DE

R081 Change of applicant/patentee

Ref document number: 1069893

Country of ref document: EP

Owner name: ORION CORP., FI

Free format text: FORMER OWNER: ORION CORP., HOSPIRA, INC., , US

Effective date: 20120921

R082 Change of representative

Ref document number: 1069893

Country of ref document: EP

Representative=s name: WINTER, BRANDL, FUERNISS, HUEBNER, ROESS, KAIS, DE

Effective date: 20120921